Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial - Quiz - MDSpire

Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial

  • By

  • Demet Özcan

  • Patricia Switten Nielsen

  • Jan Alsner

  • Mette Holck Nielsen

  • Else Maae

  • Marie Louise Holm Milo

  • Jens Overgaard

  • Birgitte Vrou Offersen

  • Trine Tramm

  • March 13, 2026

  • 0 min

Share

Original Source(s)

Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial

  • by Demet Özcan, Patricia Switten Nielsen, Jan Alsner, Mette Holck Nielsen, Else Maae, Marie Louise Holm Milo, Jens Overgaard, Birgitte Vrou Offersen, Trine Tramm

  • March 13, 2026

Related Content

HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology

Errors in Abstract and Table 1

  • May 15, 2026

Management of toxicities from antibody – drug conjugates in breast cancer